GlassScriptPhysician profile
Virginia Bahena
NPI 1992411987
$339.03
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $214 · 2024: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $66.84 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $53.88 | 2023-2024 | Rexulti |
| Novo Nordisk INC | $41.25 | 2023 | Wegovy, Ozempic, Rybelsus |
| Axsome Therapeutics, INC. | $39.00 | 2024 | Auvelity |
| Braeburn INC. | $30.09 | 2023 | Brixadi |
| Alkermes, INC. | $23.96 | 2023 | Vivitrol |
| Indivior INC. | $23.69 | 2024 | Sublocade |
| Azurity Pharmaceuticals, INC. | $16.45 | 2023 | Horizant |
| Hologic Sales and Service, LLC | $15.73 | 2024 | Aptima |
| Idorsia Pharmaceuticals US INC | $14.62 | 2023 | Quviviq |
| Harmony Biosciences LLC | $13.52 | 2023 | Wakix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virginia Bahena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.